查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1896245

人工智慧驅動的診斷和預測醫學市場預測至2032年：按組件、治療領域、數據類型、技術、應用、最終用戶和地區分類的全球分析

AI Driven Diagnostics & Predictive Care Market Forecasts to 2032 - Global Analysis By Component (Software, Hardware and Services), Disease Area, Data Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，全球人工智慧驅動的診斷和預測醫學市場預計到 2025 年將達到 19.4 億美元，到 2032 年將達到 80.1 億美元，在預測期內的複合年成長率為 22.4%。

人工智慧驅動的診斷和預測醫學是指利用人工智慧 (AI)、機器學習和進階數據分析技術來改善疾病檢測、診斷和預後。透過分析大量的臨床記錄、醫學影像、基因組資訊和即時患者數據，人工智慧系統能夠識別出有助於早期診斷和製定個人化治療方案的模式。預測醫學則專注於在症狀惡化之前預測健康風險，從而實現預防性干預。這種方法以傳統醫療實踐為基礎，並藉助數位化創新，提高了臨床準確性，降低了醫療成本，改善了患者預後，並支持建立一個積極主動、數據驅動的醫療保健生態系統。

巨量資料和進階分析

巨量資料和先進分析技術是人工智慧驅動的診斷和預測醫學市場的關鍵驅動力。電子健康記錄、醫學影像資料庫、基因組數據以及即時病患監測的日益普及，為人工智慧演算法的開發提供了沃土。先進的分析技術能夠更快地識別模式、進行風險分層並提供臨床決策支援。這些功能提高了診斷準確性，減少了人為錯誤，並有助於更早發現疾病，加速了其在全球醫院、診斷中心和研究機構的應用。

醫護人員採取謹慎態度

醫療專業人員的抵觸情緒仍是限制市場成長的主要因素。許多臨床醫生對依賴人工智慧驅動的洞察持謹慎態度，因為他們擔心臨床決策的準確性、透明度和課責。對人工智慧系統缺乏了解、擔心工作流程中斷以及對改變長期以來既定診斷實踐的抵觸情緒都在減緩人工智慧的普及。此外，人工智慧模型缺乏足夠的訓練和可解釋性，造成了信任危機，尤其是在高風險的診斷和預測性醫療應用中。

政府措施和資金籌措

政府的各項措施和資金投入為市場提供了強勁的成長機會。公共部門對數位醫療基礎設施、人工智慧研究和醫療現代化領域的投資正在加速人工智慧驅動診斷技術的應用。國家層級推行的疾病早期檢測、精準醫療和數據驅動型醫療策略，正鼓勵醫院和研究機構採用預測性醫療解決方案。津貼，政府撥款、試驗計畫和監管沙盒等機制，透過支持Start-Ups和成熟公司在公共醫療系統中推廣人工智慧技術，進一步推動了創新。

監理不確定性

監管的不確定性對市場構成重大威脅。人工智慧檢驗、數據使用、臨床責任和演算法透明度等方面的法規在不同地區差異顯著。頻繁的監管變化會增加合規成本並延緩產品核可。人工智慧輔助診斷領域責任認定方面的不明確準則為服務提供者和開發商帶來法律風險。這種不確定性可能會抑制投資、減緩創新，並限制人工智慧驅動的診斷解決方案的跨境部署。

新冠疫情的影響

新冠疫情加速了人工智慧工具在快速診斷、疾病進展預測和患者分診方面的應用，對人工智慧驅動的診斷和預測醫學市場產生了積極影響。人工智慧影像分析和預測模型為不堪重負的醫療系統提供了支援。然而，這場危機也暴露了數據品質和基礎設施的不足。總體而言，新冠疫情增強了人工智慧在臨床環境中的接受度，並凸顯了預測分析在未來醫療韌性方面的重要性。

預計在預測期內，腫瘤治療領域將佔據最大的市場佔有率。

由於腫瘤治療的高度複雜性、數據密集性以及對早期癌症檢測的迫切需求，預計在預測期內，腫瘤領域將佔據最大的市場佔有率。人工智慧驅動的診斷利用影像和基因組數據來增強腫瘤識別、預測治療反應並選擇個人化治療方案。全球癌症發生率的上升以及精準腫瘤解決方案的日益普及進一步推動了市場需求，使腫瘤領域成為人工智慧驅動的診斷和預測醫學最突出的應用領域。

預計在預測期內，診斷影像領域將呈現最高的複合年成長率。

由於人工智慧影像解決方案在精準早期疾病檢測方面的應用日益廣泛，因此診斷影像領域預計在預測期內將實現最高成長率。先進的機器學習演算法能夠提升X光、 電腦斷層掃描和MRI影像的解讀準確率，從而減少診斷錯誤並提高工作流程效率。對非侵入性快速診斷技術的需求不斷成長，以及預測分析技術的整合應用，共同推動了這一領域的成長。人工智慧成像平台和雲端解決方案的技術創新進一步加速了其在全球範圍內的應用。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率，這主要得益於醫療基礎設施的不斷完善、數位醫療的日益普及以及政府對人工智慧驅動的診斷技術投入的不斷增加。慢性病盛行率的上升、醫院網路的不斷擴展以及醫學影像設施的激增將推動市場成長。此外，公共和私營部門為實現醫療系統現代化和採用預測性醫療解決方案所採取的舉措，也正在加速人工智慧的普及。該地區經濟高效的醫療服務和龐大的患者群體，使其成為人工智慧整合的關鍵市場。

年複合成長率最高的地區

在預測期內，由於電子健康記錄 (EHR) 的廣泛應用和對人工智慧 (AI) 研究的大量投資，北美地區預計將實現最高的複合年成長率 (CAGR)。人們對精準醫療的高度重視、預測分析的日益融合以及強力的資金支持，正在推動人工智慧驅動的診斷技術的快速普及。主要技術提供者的存在和豐富的臨床數據將進一步促進成長。北美地區對創新、疾病早期檢測和個人化醫療的重視，將加速人工智慧解決方案在醫院和研究機構的應用。

免費客製化服務

購買此報告的客戶可享有以下免費自訂選項之一：

  • 公司概況
    • 最多三家新增市場參與企業進行全面分析
    • 主要參與企業（最多3家公司）的SWOT分析
  • 區域細分
    • 根據客戶要求，對主要國家進行市場估算和預測，並計算複合年成長率（註：可行性需確認）。
  • 競爭基準化分析
    • 從產品系列、地域覆蓋範圍和策略聯盟等方面對主要參與企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 摘要
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球人工智慧驅動的診斷和預測醫學市場（按組件分類）

  • 軟體
  • 硬體
    • 人工智慧成像系統
    • 穿戴式裝置和物聯網設備
    • 邊緣人工智慧設備
  • 服務
    • 實施與整合
    • 培訓和諮詢
    • 支援與維護

6. 全球人工智慧驅動的診斷和預測醫學市場（按疾病領域分類）

  • 腫瘤學
  • 心血管疾病
  • 神經系統疾病
  • 呼吸系統疾病
  • 糖尿病和代謝性疾病
  • 感染疾病
  • 罕見疾病

7. 全球人工智慧驅動的診斷和預測醫學市場（按數據類型分類）

  • 醫學影像數據
  • 電子健康紀錄（EHR）
  • 基因組/體學數據
  • 穿戴式裝置和遠端監測數據
  • 臨床記錄和非結構化數據

8. 全球人工智慧驅動的診斷和預測醫學市場（按技術分類）

  • 機器學習
  • 深度學習
  • 自然語言處理（NLP）
  • 電腦視覺
  • 人工智慧世代
  • 混合人工智慧模型

9. 全球人工智慧驅動的診斷和預測醫學市場（按應用分類）

  • 診斷影像
  • 預測醫學
    • 疾病風險預測
    • 預測患者病情惡化
    • 再入院預測
    • 治療結果預測
  • 最佳化臨床工作流程
  • 人口健康管理

第10章 全球人工智慧驅動的診斷和預測醫學市場（按最終用戶分類）

  • 醫院診所
  • 影像中心
  • 門診治療中心
  • 學術和研究機構
  • 醫療保險公司
  • 製藥和生物技術公司

第11章 區域人工智慧驅動的診斷與預測醫學市場

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章：企業概況

  • Siemens Healthineers
  • Butterfly Network
  • GE HealthCare
  • Enlitic
  • Aidoc
  • Lunit
  • IBM Watson Health
  • Arterys
  • Philips Healthcare
  • Paige AI
  • Zebra Medical Vision
  • Qure.ai
  • Tempus
  • Freenome
  • PathAI
Product Code: SMRC32933

According to Stratistics MRC, the Global AI Driven Diagnostics & Predictive Care Market is accounted for $1.94 billion in 2025 and is expected to reach $8.01 billion by 2032 growing at a CAGR of 22.4% during the forecast period. AI Driven Diagnostics & Predictive Care refers to the use of artificial intelligence, machine learning, and advanced data analytics to improve disease detection, diagnosis, and outcome prediction. By analyzing vast volumes of clinical records, medical imaging, genomics, and real-time patient data, AI systems identify patterns that support early diagnosis and personalized treatment planning. Predictive care focuses on anticipating health risks before symptoms escalate, enabling preventive interventions. Grounded in traditional medical practice and strengthened by digital innovation, this approach enhances clinical accuracy, reduces healthcare costs, improves patient outcomes, and supports a proactive, data-driven healthcare ecosystem.

Market Dynamics:

Driver:

Big Data & Advanced Analytics

Big data and advanced analytics are the central drivers of the AI Driven Diagnostics & Predictive Care Market. The growing availability of electronic health records, medical imaging databases, genomic data, and real-time patient monitoring creates fertile ground for AI algorithms. Advanced analytics enable faster pattern recognition, risk stratification, and clinical decision support. These capabilities improve diagnostic precision, reduce human error, and allow early disease detection, accelerating adoption across hospitals, diagnostic centers, and research institutions worldwide.

Restraint:

Reluctance among Medical Practitioners

Reluctance among medical practitioners remains a key restraint to market growth. Many clinicians are cautious about relying on AI-driven insights due to concerns over accuracy, transparency, and accountability in clinical decision-making. Limited understanding of AI systems, fear of workflow disruption, and resistance to changing long-established diagnostic practices slows adoption. Additionally, lack of adequate training and explainability in AI models creates trust gaps, particularly in high-stakes diagnostic and predictive care applications.

Opportunity:

Government Initiatives & Funding

Government initiatives and funding present's strong growth opportunities for the market. Public investments in digital health infrastructure, AI research, and healthcare modernization are accelerating adoption of AI-driven diagnostics. National strategies promoting early disease detection, precision medicine, and data-driven healthcare encourage hospitals and research institutions to deploy predictive care solutions. Grants, pilot programs, and regulatory sandboxes further support innovation, enabling startups and established players to scale AI technologies across public healthcare systems.

Threat:

Regulatory Uncertainty

Regulatory uncertainty poses a significant threat to the market. Regulations governing AI validation, data usage, clinical liability, and algorithm transparency vary widely across regions. Frequent regulatory changes increase compliance costs and delay product approvals. Unclear guidelines on accountability in AI-assisted diagnosis create legal risks for providers and developers. This uncertainty can discourage investment, slow innovation, and restrict cross-border deployment of AI-driven diagnostic solutions.

Covid-19 Impact:

The COVID-19 pandemic positively influenced the AI Driven Diagnostics & Predictive Care Market by accelerating adoption of AI tools for rapid diagnosis, disease progression prediction, and patient triage. AI-powered imaging analysis and predictive models supported overwhelmed healthcare systems. However, the crisis also exposed data quality gaps and infrastructure limitations. Overall, COVID-19 strengthened acceptance of AI in clinical settings and reinforced the importance of predictive analytics for future healthcare resilience.

The oncology segment is expected to be the largest during the forecast period

The oncology segment is expected to account for the largest market share during the forecast period, due to the high complexity, data intensity, and critical need for early cancer detection. AI-driven diagnostics enhance tumor identification, treatment response prediction, and personalized therapy selection using imaging and genomic data. Rising global cancer prevalence and increasing adoption of precision oncology solutions further drive demand, making oncology the most prominent application area for AI-driven diagnostics and predictive care.

The diagnostic imaging segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the diagnostic imaging segment is predicted to witness the highest growth rate, due to increasing adoption of AI-powered imaging solutions for precise and early disease detection. Advanced machine learning algorithms enhance interpretation of X-rays, CT scans, and MRIs, reducing diagnostic errors and improving workflow efficiency. Rising demand for non-invasive, rapid diagnostic techniques, coupled with the integration of predictive analytics, fuels growth. Technological innovations in AI-enabled imaging platforms and cloud-based solutions further accelerate adoption globally.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to expanding healthcare infrastructure, growing digital health adoption, and increasing government investments in AI-driven diagnostics. Rising prevalence of chronic diseases, expanding hospital networks, and a surge in medical imaging facilities support market growth. Additionally, public and private sector initiatives to modernize healthcare systems and deploy predictive care solutions accelerate adoption. The region's cost-effective healthcare services and large patient population make it a prime market for AI integration.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to widespread electronic health record adoption, and significant AI research investments. High awareness of precision medicine, increasing integration of predictive analytics, and strong funding support drive rapid deployment of AI-driven diagnostics. The presence of leading technology providers and extensive clinical data availability further fuels growth. North America's focus on innovation, early disease detection, and personalized care ensures accelerated adoption of AI solutions across hospitals and research institutions.

Key players in the market

Some of the key players in AI Driven Diagnostics & Predictive Care Market include Siemens Healthineers, Butterfly Network, GE HealthCare, Enlitic, Aidoc, Lunit, IBM Watson Health, Arterys, Philips Healthcare, Paige AI, Zebra Medical Vision, Qure.ai, Tempus, Freenome, and PathAI.

Key Developments:

In November 2025, Siemens Healthineers introduced Syngo Carbon 2.0, an upgraded enterprise imaging platform. The launch integrates multimodal imaging data, AI-powered workflow automation, and cloud-based collaboration, designed to streamline radiology operations and improve diagnostic accuracy across global healthcare systems.

In October 2025, Siemens Healthineers expanded its collaboration with Varian and multiple oncology centers to accelerate precision therapy solutions. The joint venture integrates imaging, radiation therapy, and AI-driven planning tools, aiming to improve cancer treatment outcomes and strengthen Siemens' leadership in oncology care.

Components Covered:

  • Software
  • Hardware
  • Services

Disease Areas Covered:

  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Respiratory Diseases
  • Diabetes & Metabolic Disorders
  • Infectious Diseases
  • Rare Diseases

Data Types Covered:

  • Medical Imaging Data
  • Electronic Health Records (EHR)
  • Genomic & Omics Data
  • Wearable & Remote Monitoring Data
  • Clinical Notes & Unstructured Data

Technologies Covered:

  • Machine Learning
  • Deep Learning
  • Natural Language Processing (NLP)
  • Computer Vision
  • Generative AI
  • Hybrid AI Models

Applications Covered:

  • Diagnostic Imaging
  • Predictive Care
  • Clinical Workflow Optimization
  • Population Health Management

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Imaging Centers
  • Ambulatory Care Centers
  • Academic & Research Institutes
  • Healthcare Payers
  • Pharmaceutical & Biotechnology Companies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global AI Driven Diagnostics & Predictive Care Market, By Component

  • 5.1 Introduction
  • 5.2 Software
  • 5.3 Hardware
    • 5.3.1 AI-Enabled Imaging Systems
    • 5.3.2 Wearable & IoT Devices
    • 5.3.3 Edge AI Devices
  • 5.4 Services
    • 5.4.1 Implementation & Integration
    • 5.4.2 Training & Consulting
    • 5.4.3 Support & Maintenance

6 Global AI Driven Diagnostics & Predictive Care Market, By Disease Area

  • 6.1 Introduction
  • 6.2 Oncology
  • 6.3 Cardiovascular Diseases
  • 6.4 Neurological Disorders
  • 6.5 Respiratory Diseases
  • 6.6 Diabetes & Metabolic Disorders
  • 6.7 Infectious Diseases
  • 6.8 Rare Diseases

7 Global AI Driven Diagnostics & Predictive Care Market, By Data Type

  • 7.1 Introduction
  • 7.2 Medical Imaging Data
  • 7.3 Electronic Health Records (EHR)
  • 7.4 Genomic & Omics Data
  • 7.5 Wearable & Remote Monitoring Data
  • 7.6 Clinical Notes & Unstructured Data

8 Global AI Driven Diagnostics & Predictive Care Market, By Technology

  • 8.1 Introduction
  • 8.2 Machine Learning
  • 8.3 Deep Learning
  • 8.4 Natural Language Processing (NLP)
  • 8.5 Computer Vision
  • 8.6 Generative AI
  • 8.7 Hybrid AI Models

9 Global AI Driven Diagnostics & Predictive Care Market, By Application

  • 9.1 Introduction
  • 9.2 Diagnostic Imaging
  • 9.3 Predictive Care
    • 9.3.1 Disease Risk Prediction
    • 9.3.2 Patient Deterioration Prediction
    • 9.3.3 Hospital Readmission Prediction
    • 9.3.4 Treatment Outcome Prediction
  • 9.4 Clinical Workflow Optimization
  • 9.5 Population Health Management

10 Global AI Driven Diagnostics & Predictive Care Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals & Clinics
  • 10.3 Diagnostic Imaging Centers
  • 10.4 Ambulatory Care Centers
  • 10.5 Academic & Research Institutes
  • 10.6 Healthcare Payers
  • 10.7 Pharmaceutical & Biotechnology Companies

11 Global AI Driven Diagnostics & Predictive Care Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Siemens Healthineers
  • 13.2 Butterfly Network
  • 13.3 GE HealthCare
  • 13.4 Enlitic
  • 13.5 Aidoc
  • 13.6 Lunit
  • 13.7 IBM Watson Health
  • 13.8 Arterys
  • 13.9 Philips Healthcare
  • 13.10 Paige AI
  • 13.11 Zebra Medical Vision
  • 13.12 Qure.ai
  • 13.13 Tempus
  • 13.14 Freenome
  • 13.15 PathAI

List of Tables

  • Table 1 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Software (2024-2032) ($MN)
  • Table 4 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 5 Global AI Driven Diagnostics & Predictive Care Market Outlook, By AI-Enabled Imaging Systems (2024-2032) ($MN)
  • Table 6 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Wearable & IoT Devices (2024-2032) ($MN)
  • Table 7 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Edge AI Devices (2024-2032) ($MN)
  • Table 8 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Services (2024-2032) ($MN)
  • Table 9 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Implementation & Integration (2024-2032) ($MN)
  • Table 10 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Training & Consulting (2024-2032) ($MN)
  • Table 11 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Support & Maintenance (2024-2032) ($MN)
  • Table 12 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Disease Area (2024-2032) ($MN)
  • Table 13 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 14 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Cardiovascular Diseases (2024-2032) ($MN)
  • Table 15 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Neurological Disorders (2024-2032) ($MN)
  • Table 16 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Respiratory Diseases (2024-2032) ($MN)
  • Table 17 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Diabetes & Metabolic Disorders (2024-2032) ($MN)
  • Table 18 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Infectious Diseases (2024-2032) ($MN)
  • Table 19 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Rare Diseases (2024-2032) ($MN)
  • Table 20 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Data Type (2024-2032) ($MN)
  • Table 21 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Medical Imaging Data (2024-2032) ($MN)
  • Table 22 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Electronic Health Records (EHR) (2024-2032) ($MN)
  • Table 23 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Genomic & Omics Data (2024-2032) ($MN)
  • Table 24 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Wearable & Remote Monitoring Data (2024-2032) ($MN)
  • Table 25 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Clinical Notes & Unstructured Data (2024-2032) ($MN)
  • Table 26 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Technology (2024-2032) ($MN)
  • Table 27 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Machine Learning (2024-2032) ($MN)
  • Table 28 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Deep Learning (2024-2032) ($MN)
  • Table 29 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Natural Language Processing (NLP) (2024-2032) ($MN)
  • Table 30 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Computer Vision (2024-2032) ($MN)
  • Table 31 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Generative AI (2024-2032) ($MN)
  • Table 32 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Hybrid AI Models (2024-2032) ($MN)
  • Table 33 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Application (2024-2032) ($MN)
  • Table 34 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Diagnostic Imaging (2024-2032) ($MN)
  • Table 35 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Predictive Care (2024-2032) ($MN)
  • Table 36 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Disease Risk Prediction (2024-2032) ($MN)
  • Table 37 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Patient Deterioration Prediction (2024-2032) ($MN)
  • Table 38 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Hospital Readmission Prediction (2024-2032) ($MN)
  • Table 39 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Treatment Outcome Prediction (2024-2032) ($MN)
  • Table 40 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Clinical Workflow Optimization (2024-2032) ($MN)
  • Table 41 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Population Health Management (2024-2032) ($MN)
  • Table 42 Global AI Driven Diagnostics & Predictive Care Market Outlook, By End User (2024-2032) ($MN)
  • Table 43 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 44 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Diagnostic Imaging Centers (2024-2032) ($MN)
  • Table 45 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Ambulatory Care Centers (2024-2032) ($MN)
  • Table 46 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 47 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Healthcare Payers (2024-2032) ($MN)
  • Table 48 Global AI Driven Diagnostics & Predictive Care Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.